Literature DB >> 28049161

Phase I Trial: SABR and Ipilimumab-Response.

Chad Tang1, James W Welsh2, David Hong2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28049161      PMCID： PMC5215783          DOI： 10.1158/1078-0432.CCR-16-2621

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  5 in total

1.  Abscopal effect in a patient with melanoma.

Authors:  Susan M Hiniker; Daniel S Chen; Susan J Knox
Journal:  N Engl J Med       Date:  2012-05-24       Impact factor: 91.245

2.  Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells.

Authors:  Timothy M Illidge; Jamie Honeychurch; Simon J Dovedi; Grazyna Lipowska-Bhalla; Stephen A Beers; Eleanor J Cheadle; Lijun Mu; Martin J Glennie
Journal:  Cancer Immunol Res       Date:  2016-05-30       Impact factor: 11.151

3.  Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells.

Authors:  Chad Tang; James W Welsh; Patricia de Groot; Erminia Massarelli; Joe Y Chang; Kenneth R Hess; Sreyashi Basu; Michael A Curran; Maria E Cabanillas; Vivek Subbiah; Siqing Fu; Apostolia M Tsimberidou; Daniel Karp; Daniel R Gomez; Adi Diab; Ritsuko Komaki; John V Heymach; Padmanee Sharma; Aung Naing; David S Hong
Journal:  Clin Cancer Res       Date:  2016-09-20       Impact factor: 12.531

4.  A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma.

Authors:  Susan M Hiniker; Sunil A Reddy; Holden T Maecker; Priyanka B Subrahmanyam; Yael Rosenberg-Hasson; Susan M Swetter; Saurabh Saha; Lei Shura; Susan J Knox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-07-15       Impact factor: 7.038

5.  Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.

Authors:  Christina Twyman-Saint Victor; Andrew J Rech; Amit Maity; Ramesh Rengan; Kristen E Pauken; Erietta Stelekati; Joseph L Benci; Bihui Xu; Hannah Dada; Pamela M Odorizzi; Ramin S Herati; Kathleen D Mansfield; Dana Patsch; Ravi K Amaravadi; Lynn M Schuchter; Hemant Ishwaran; Rosemarie Mick; Daniel A Pryma; Xiaowei Xu; Michael D Feldman; Tara C Gangadhar; Stephen M Hahn; E John Wherry; Robert H Vonderheide; Andy J Minn
Journal:  Nature       Date:  2015-03-09       Impact factor: 49.962
  5 in total
  1 in total

Review 1.  Radiotherapy for Melanoma: More than DNA Damage.

Authors:  Susanne J Rogers; Emsad Puric; Brigitte Eberle; Niloy R Datta; Stephan B Bodis
Journal:  Dermatol Res Pract       Date:  2019-04-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.